In the pharma industry, do we believe that the gap between what our businesses promise and what results our businesses …
Pfizer has earmarked an 11 million euro investment for a new kilo-scale R&D facility at its manufacturing facility in Ringaskiddy, …
Pfizer has halted a phase III trial for its oncology hope Sutent, after it failed to show significant improvement in …
US drugmaker Pfizer has been in emergency talks with the government of Venezuela after being threatened with seizure of a …
Pfizer has expanded its presence in the generics market with deals that see it licence 75 products from two Indian …
Pharmafocus presents a round-up of developments in the pharmaceutical manufacturing sector, including Pfizer's increased adoption of contract manufacturing and facility …
Pfizer saw its performance dip in the first quarter of 2009, with revenue down 8% year-on-year. The company, which is …
Pfizer's Dr Ponni Subbiah is at the forefront of a revolution in the way the pharma industry views its business, …
Pfizer will work with researchers from University College London in the UK to try to develop stem cell-based therapies for …
As a young child, I am reliably informed that "why" was my favourite word for an extended period. While that …
GSK and Pfizer have agreed to merge their respective HIV businesses, creating a single specialist entity with total pro-forma sales …
The world's two biggest pharma companies are to join forces to develop and market new treatments for HIV.GlaxoSmithKline is a …
Pfizer has unveiled the new structure of the merged company created by its proposed acquisition of Wyeth. It plans to …
Contract research organisations now play an indispensable role in helping pharmaceutical companies develop their drugs. But as the number and …